Bioqual (OTCMKTS:BIOQ) Stock Price Down 6.2% – Here’s What Happened

Bioqual, Inc. (OTCMKTS:BIOQGet Free Report)’s share price dropped 6.2% during trading on Thursday . The stock traded as low as $57.50 and last traded at $57.50. Approximately 500 shares were traded during mid-day trading, an increase of 150% from the average daily volume of 200 shares. The stock had previously closed at $61.30.

Bioqual Stock Down 6.2 %

The business has a 50 day moving average price of $60.48 and a two-hundred day moving average price of $64.90. The stock has a market cap of $51.41 million, a P/E ratio of -18.37 and a beta of -0.33.

Bioqual (OTCMKTS:BIOQGet Free Report) last announced its quarterly earnings data on Tuesday, January 21st. The company reported ($1.36) earnings per share (EPS) for the quarter. Bioqual had a negative net margin of 5.54% and a negative return on equity of 7.50%.

Bioqual Company Profile

(Get Free Report)

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.

Featured Stories

Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.